Publication:
Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves.

cris.virtualsource.author-orcidb7cda86d-8924-42a5-973a-d73fee5c630b
cris.virtualsource.author-orcid101f1394-72d5-4dda-b28f-666a3dee6c70
dc.contributor.authorPagnesi, Matteo
dc.contributor.authorKim, Won-Keun
dc.contributor.authorBaggio, Sara
dc.contributor.authorScotti, Andrea
dc.contributor.authorBarbanti, Marco
dc.contributor.authorDe Marco, Federico
dc.contributor.authorAdamo, Marianna
dc.contributor.authorEitan, Amnon
dc.contributor.authorEstévez-Loureiro, Rodrigo
dc.contributor.authorConradi, Lenard
dc.contributor.authorToggweiler, Stefan
dc.contributor.authorMylotte, Darren
dc.contributor.authorVeulemans, Verena
dc.contributor.authorSondergaard, Lars
dc.contributor.authorWolf, Alexander
dc.contributor.authorGiannini, Francesco
dc.contributor.authorMaffeo, Diego
dc.contributor.authorPilgrim, Thomas
dc.contributor.authorMontorfano, Matteo
dc.contributor.authorZweiker, David
dc.contributor.authorFerlini, Marco
dc.contributor.authorKornowski, Ran
dc.contributor.authorHildick-Smith, David
dc.contributor.authorTaramasso, Maurizio
dc.contributor.authorAbizaid, Alexandre
dc.contributor.authorSchofer, Joachim
dc.contributor.authorSinning, Jan-Malte
dc.contributor.authorVan Mieghem, Nicolas M
dc.contributor.authorWöhrle, Jochen
dc.contributor.authorKhogali, Saib
dc.contributor.authorVan der Heyden, Jan A S
dc.contributor.authorWood, David A
dc.contributor.authorIelasi, Alfonso
dc.contributor.authorMacCarthy, Philip
dc.contributor.authorBrugaletta, Salvatore
dc.contributor.authorHamm, Christian W
dc.contributor.authorCosta, Giuliano
dc.contributor.authorTesta, Luca
dc.contributor.authorMassussi, Mauro
dc.contributor.authorAlarcón, Robert
dc.contributor.authorSchäfer, Ulrich
dc.contributor.authorBrunner, Stephanie
dc.contributor.authorReimers, Bernhard
dc.contributor.authorLunardi, Mattia
dc.contributor.authorZeus, Tobias
dc.contributor.authorVanhaverbeke, Maarten
dc.contributor.authorNaber, Christoph K
dc.contributor.authorDi Ienno, Luca
dc.contributor.authorBuono, Andrea
dc.contributor.authorWindecker, Stephan
dc.contributor.authorSchmidt, Albrecht
dc.contributor.authorLanzillo, Giuseppe
dc.contributor.authorVaknin-Assa, Hana
dc.contributor.authorArunothayaraj, Sandeep
dc.contributor.authorSaccocci, Matteo
dc.contributor.authorSiqueira, Dimytri
dc.contributor.authorBrinkmann, Christina
dc.contributor.authorSedaghat, Alexander
dc.contributor.authorZiviello, Francesca
dc.contributor.authorSeeger, Julia
dc.contributor.authorRottbauer, Wolfgang
dc.contributor.authorBrouwer, Jorn
dc.contributor.authorBuysschaert, Ian
dc.contributor.authorJelisejevas, Julius
dc.contributor.authorBharucha, Apurva
dc.contributor.authorRegueiro, Ander
dc.contributor.authorMetra, Marco
dc.contributor.authorColombo, Antonio
dc.contributor.authorLatib, Azeem
dc.contributor.authorMangieri, Antonio
dc.date.accessioned2024-10-25T16:58:48Z
dc.date.available2024-10-25T16:58:48Z
dc.date.issued2023-08-28
dc.description.abstractOBJECTIVES The authors sought to evaluate the incidence, predictors, and outcomes of new permanent pacemaker implantation (PPI) after transcatheter aortic valve replacement (TAVR) with contemporary self-expanding valves (SEV). BACKGROUND Need for PPI is frequent post-TAVR, but conflicting data exist on new-generation SEV and on the prognostic impact of PPI. METHODS This study included 3,211 patients enrolled in the multicenter NEOPRO (A Multicenter Comparison of Acurate NEO Versus Evolut PRO Transcatheter Heart Valves) and NEOPRO-2 (A Multicenter Comparison of ACURATE NEO2 Versus Evolut PRO/PRO+ Transcatheter Heart Valves 2) registries (January 2012 to December 2021) who underwent transfemoral TAVR with SEV. Implanted transcatheter heart valves (THV) were Acurate neo (n = 1,090), Acurate neo2 (n = 665), Evolut PRO (n = 1,312), and Evolut PRO+ (n = 144). Incidence and predictors of new PPI and 1-year outcomes were evaluated. RESULTS New PPI was needed in 362 patients (11.3%) within 30 days after TAVR (8.8%, 7.7%, 15.2%, and 10.4%, respectively, after Acurate neo, Acurate neo2, Evolut PRO, and Evolut PRO+). Independent predictors of new PPI were Society of Thoracic Surgeons Predicted Risk of Mortality score, baseline right bundle branch block and depth of THV implantation, both in patients treated with Acurate neo/neo2 and in those treated with Evolut PRO/PRO+. Predischarge reduction in ejection fraction (EF) was more frequent in patients requiring PPI (P = 0.014). New PPI was associated with higher 1-year mortality (16.9% vs 10.8%; adjusted HR: 1.66; 95% CI: 1.13-2.43; P = 0.010), particularly in patients with baseline EF <40% (P for interaction = 0.049). CONCLUSIONS New PPI was frequently needed after TAVR with SEV (11.3%) and was associated with higher 1-year mortality, particularly in patients with EF <40%. Baseline right bundle branch block and depth of THV implantation independently predicted the need of PPI.
dc.description.numberOfPages14
dc.description.sponsorshipUniversitätsklinik für Kardiologie
dc.identifier.doi10.48350/185007
dc.identifier.pmid37480891
dc.identifier.publisherDOI10.1016/j.jcin.2023.05.020
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/168893
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofJACC. Cardiovascular Interventions
dc.relation.issn1876-7605
dc.relation.organizationDCD5A442BB15E17DE0405C82790C4DE2
dc.subjectAcurate neo Evolut PRO mortality pacemaker self-expanding transcatheter aortic valve replacement
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleIncidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage2017
oaire.citation.issue16
oaire.citation.startPage2004
oaire.citation.volume16
oairecerif.author.affiliationUniversitätsklinik für Kardiologie
oairecerif.author.affiliationUniversitätsklinik für Kardiologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2023-07-26 01:33:49
unibe.description.ispublishedpub
unibe.eprints.legacyId185007
unibe.journal.abbrevTitleJACC-CARDIOVASC INTE
unibe.refereedTRUE
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
1-s2.0-S1936879823008464-main.pdf
Size:
899.01 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
published

Collections